Resistance to Targeted Therapies in Lymphomas
This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but also help...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Xavier, Ana C. (Editor, http://id.loc.gov/vocabulary/relators/edt), Cairo, Mitchell S. (Editor, http://id.loc.gov/vocabulary/relators/edt) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
| Edition: | 1st ed. 2019. |
| Series: | Resistance to Targeted Anti-Cancer Therapeutics,
21 |
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
Published: (2018) -
Resistance to Ibritumomab in Lymphoma
Published: (2018) -
Current Applications for Overcoming Resistance to Targeted Therapies
Published: (2019) -
Cancer Stem Cell Resistance to Targeted Therapy
Published: (2019) -
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Published: (2018)